| Acquired immunity to malaria DL Doolan, C Dobaño, JK Baird Clinical microbiology reviews 22 (1), 13-36, 2009 | 1727 | 2009 |
| Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine R Wang, DL Doolan, TP Le, RC Hedstrom, KM Coonan, Y Charoenvit, ... Science 282 (5388), 476-480, 1998 | 1157 | 1998 |
| Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites SL Hoffman, LML Goh, TC Luke, I Schneider, TP Le, DL Doolan, J Sacci, ... The Journal of infectious diseases 185 (8), 1155-1164, 2002 | 1020 | 2002 |
| A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray PD Crompton, MA Kayala, B Traore, K Kayentao, A Ongoiba, GE Weiss, ... Proceedings of the National Academy of Sciences 107 (15), 6958-6963, 2010 | 532 | 2010 |
| The complexity of protective immunity against liver-stage malaria DL Doolan, SL Hoffman The journal of immunology 165 (3), 1453-1462, 2000 | 451 | 2000 |
| The rise of non-tuberculosis mycobacterial lung disease CN Ratnatunga, VP Lutzky, A Kupz, DL Doolan, DW Reid, M Field, ... Frontiers in immunology 11, 303, 2020 | 413 | 2020 |
| Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. DL Doolan, M Sedegah, RC Hedstrom, P Hobart, Y Charoenvit, ... The Journal of experimental medicine 183 (4), 1739-1746, 1996 | 362 | 1996 |
| Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. VP Argaet, CW Schmidt, SR Burrows, SL Silins, MG Kurilla, DL Doolan, ... The Journal of experimental medicine 180 (6), 2335-2340, 1994 | 339 | 1994 |
| Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers TP Le, KM Coonan, RC Hedstrom, Y Charoenvit, M Sedegah, JE Epstein, ... Vaccine 18 (18), 1893-1901, 2000 | 328 | 2000 |
| Immune effector mechanisms in malaria MF Good, DL Doolan Current opinion in immunology 11 (4), 412-419, 1999 | 328 | 1999 |
| Profiling humoral immune responses to P. falciparum infection with protein microarrays DL Doolan, Y Mu, B Unal, S Sundaresh, S Hirst, C Valdez, A Randall, ... Proteomics 8 (22), 4680-4694, 2008 | 318 | 2008 |
| Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data DL Doolan, S Southwood, DA Freilich, J Sidney, NL Graber, L Shatney, ... Proceedings of the National Academy of Sciences 100 (17), 9952-9957, 2003 | 280 | 2003 |
| Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine R Wang, J Epstein, FM Baraceros, EJ Gorak, Y Charoenvit, DJ Carucci, ... Proceedings of the National Academy of Sciences 98 (19), 10817-10822, 2001 | 280 | 2001 |
| IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model DL Doolan, SL Hoffman The Journal of Immunology 163 (2), 884-892, 1999 | 264 | 1999 |
| Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles DL Doolan, SL Hoffman, S Southwood, PA Wentworth, J Sidney, ... Immunity 7 (1), 97-112, 1997 | 261 | 1997 |
| Interleukin-12-and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice RA Gramzinski, DL Doolan, M Sedegah, HL Davis, AM Krieg, SL Hoffman Infection and immunity 69 (3), 1643-1649, 2001 | 209 | 2001 |
| Suboptimal SARS-CoV-2− specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype JR Habel, THO Nguyen, CE van de Sandt, JA Juno, P Chaurasia, ... Proceedings of the National Academy of Sciences 117 (39), 24384-24391, 2020 | 208 | 2020 |
| Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens A Trieu, MA Kayala, C Burk, DM Molina, DA Freilich, TL Richie, P Baldi, ... Molecular & Cellular Proteomics 10 (9), M111. 007948, 2011 | 191 | 2011 |
| Estimating the global burden of Epstein–Barr virus-related cancers Y Wong, MT Meehan, SR Burrows, DL Doolan, JJ Miles Journal of Cancer Research and Clinical Oncology, 1-16, 2022 | 189 | 2022 |
| DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity I Chuang, M Sedegah, S Cicatelli, M Spring, M Polhemus, C Tamminga, ... PloS one 8 (2), e55571, 2013 | 168 | 2013 |
Alessandro SetteE-mail megerősítve itt: liai.org
